Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma

In our previous study, a liver-targeting peptide CSP I-plus modified recombinant human Endostatin (rEndostatin, endostar) (rES-CSP) was constructed and showed potent antiangiogenic capability and could specifically bind to human hepatocellular carcinoma cells to make a direct inhibition in vitro. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Ma, Dongmei, Bao, Jingjing, Zhang, Xiaobao, Jin, Jie, Wang, Yan, Wang, Jiayong, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658401/
https://www.ncbi.nlm.nih.gov/pubmed/29075040
http://dx.doi.org/10.1038/s41598-017-14320-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658401/
https://www.ncbi.nlm.nih.gov/pubmed/29075040
http://dx.doi.org/10.1038/s41598-017-14320-0

Ejemplares similares